In 1958, in a paper on the factors in the prognosis of carcinoma of the kidney, Sir Eric Riches stated that there was general agreement on the average survival rate: thus approximately 50 % of patients survived for three years, 40% for five years and only 20% lived for ten years. Of all neoplasms, this is one of the most unpredictable to treat but it is possible to list some of the factors on which the eventual results of treatment will depend. In Riches' opinion these are as follows: the histological grade of the tumour; involvement of the renal vein; invasion of lymph nodes; local extension of the growth; presence of metastases; method of treatment.
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Not everyone may agree with the order, but these factors at least suggest a reasonable method of approaching the problem. In discussing the prognosis of renal cell carcinoma, one is struck by the fact that in few papers is there any attempt to distinguish between patients with or without secondary deposits. Furthermore, even though Riches and his co-authors pointed out the significance of renal vein involvement at nephrectomy as long ago as 1951, this has been largely ignored; we suspect that this is because many papers are the results of a retrospective study.
Haemotogenous Spread
In the series of patients reported by Riches et al. in 1951, it is seen that, five years after nephrectomy, the survival in those patients vein free was 35% as compared with 16% if the vein was involved. Even when the patient has had postoperative irradiation the results are similarly weighted for the vein free of tumour 50%Y., versus 'Present address: St George's Hospital, London 36 % for the vein involved. But whether the vein is free or not of tumour at operation, there is a steady deterioration in survival up to ten years after nephrectomy. For example, in those patients in whom the vein is free of tumour the survival after nephrectomy is 83% at one year, 49% at three years, 35% at five years and 21 % at ten years. When radiotherapy is given postoperatively the figures are slightly better, as follows: 88 % survive one year, 55 % three years, 50 % five years and 27 % ten years. As virtually all the patients who died did so as a result of metastases, spread must have occurred by the blood stream at or before operation.
This point has been convincingly demonstrated in a patient operated on by Mr C H Kinder for a hypernephroma, with no clinical evidence of secondary spread. The renal vein appeared free of tumour. Blood was taken simultaneously from the renal vein distally after the clamp had been applied to that vessel, and from a peripheral vein in the antecubital fossa. Both samples showed the presence ofmalignant cells in the blood confirming that tumour cells had been and were being liberated into the circulation at operation. It has been shown by Watne et al. (1961) that there is a significantly decreased survival at eighteen months for those patients in whom tumour cells were found in the peripheral blood pre-operatively. Engell (1959) , in a follow-up of 125 patients five to nine years after surgery, found that the difference in survival between those who had a positive blood and those who did not was approximately 20%.
Detection ofCirculating Cancer Cells
Since Engell (1955) published his first paper on the isolation of circulating cancer cells, great interest has been shown in this aspect of cytology but, in spite of extensive work in this field over the last decade as reviewed by Goldblatt & Nadel (1963) , there is at present no widespread agreement as to the cytological criteria for the recognition of these cells. We have felt confident of our ability to recognize the obvious groups of 17 283 284 Proc. roy. Soc. Mecd. Volume 61 March 1968 malignant cells and have used, for comparison, tumour contact prints which have helped to demonstrate the similarities of the cells isolated from the blood and those from the cut surface of the tumour. The difficulty of their identification apart, the importance of the presence of these cells depends on one other factor, namely their viability at the time of their isolation. There is at present no satisfactory method of demonstrating this by histochemical stains. Thus the mere examination of blood for circulating cancer cells is of great interest but oflittle practical significance at present. But the quantitative aspect of this examination, especially at operation, has proved valuable, a view supported by Griffiths (1966) .
A method has been described of detecting viable cancer cells in an experimental model (Gazet 1966) . This is now being investigated in human patients and is pertinent to the present discussion. Briefly, a tumour (in this case, V2) was transplanted into the thigh of a rabbit (Fig 1) . When the tumour had grown to a palpable size, the contralateral femoral vein was cannulated under antesthesia; this enabled blood to be obtained from the inferior vena cava at will. The tumour was then manipulated for a minute. Thereafter, samples of blood were withdrawn as quickly as possible at intervals of time following manipulation and examined for tumour cells. Half the specimen of blood was kept, to test the viability of these cells by growth in another animal. Immediately after manipulation there was a sharp risc in the numbers of tumour cells detected, then a rapid fall-off ( Fig 2) . This method has been shown to give consistently reproducible results. The similarity of this experimental model to that which occurs at nephrectomy for hypernephroma is apparent in the diagrams taken from a paper by Roberts et al. (1958) (Fig 3) and in a similar patient in whom the tumour was inoperable (Fig 4) The number of tumour cells per ml was obtained by quantitative estimation of these cells in rabbit blood using Christopherson's millipore methcd
The importance of this becomes apparent when it is shown that two-thirds of the cells liberated by manipulation in the experimental model are viable as demonstrated by their growth in mice (Table 1 ). It follows that the greater the total number of cells found, the greater the number of viable tumour cells in the circulation. Applying the analogy of this animal experiment to man, one might expect the development of metastases following surgery in those patients in whom the total numbers of tumour cells detected at nephrectomy is the highest. Clinical Investigation Over a period of a year, we have examined this problem with Mr F R Kilpatrick and Mr C H Kinder in their personal series of 12 patients ( Table 2 ). The first point noted from this depressing Table is that we have only one patient in whom there was no evidence of spread except for the liberation of tumour cells at operation. To date this patient is alive and well. All 12 patients underwent nephrectomy and, from a limited follow up at two years, 50 % are already dead. We have not done a histological grading of the tumour, nor have we sufficient data on the involvement of lymph nodes from the specimens, but certainly renal vein involvement which was present in 7 patients carried a high mortality: 4 are already dead. Local spread likewise is a serious complication as, to date, 2 out of the 4 have died. Those with proven hematogenous spread have, as expected, a high mortality. Five patients had positive blood samples for tumour cells; 4 of these were associated with renal vein involvement; yet only one of those 5 patients had evidence of distant metastases at operation. In 3 cases the actual number of cells detected (Table 3) was small. Only one specimen of blood, at a particular time, was taken in any one case; this, in part, explains the low yield of positive regional blood samples but, when the blood examined is taken distal to the clamp, as seen in 2 patients, the recovery rate of tumour cells increases tenfold.
Thus, in patient number 10, the only one in whom curative surgery would seem to have succeeded, a positive regional blood sample was found. Returning now to the significance of circulating cancer cells, the particular point of tumour cell viability assumes greater importance when it is realized that, according to Riches et al. (1951) , of the patients operated upon without renal vein involvement or the obvious presence of secondary deposits, 17 % are dead within one year in spite of radiotherapy and 83-89% are dead within ten years. Clearly hkmatogenous spread has occurred before or at the time of surgery and the tumour cells liberated were viable. In the circumstances little can be done but, when tumour cells are only or mainly detected at operation, this particular hazard should be recognized and if possible dealt with. Table 3 Circulating tumour cell counts in patients with hypernephroma (from 20ml blood taken at nephrectomy) 
Discussion
In grappling with the problem of treatment of this difficult condition, the ideal of eradication of the early growth is seldom reached due to the lateness at which the disease is commonly seen. At present we accept the standard treatment as nephrectomy with preor post-operative irradiation, with or without the treatment of distant metastases when present as part of the primary or secondary treatment. Nephrectomy alone, from Riches' work, is unacceptable: at least we should give post-operative irradiation routinely. Preoperative irradiation has as yet not been fully evaluated but could present certain problems.
Ancillary methods of treatment have been suggested. The administration of cytotoxic drugs by regional perfusion is attractive. Certainly many patients will have arteriograms prior to surgery and Grabstald (1964) has suggested that this would offer an ideal opportunity for drug therapy; he has reported 3 cases where he has done this prior to nephrectomy, using 5-fluorouracil, but he was not impressed with the effect of this drug on the tumour. Considering this proposition from another point of view, it would seem reasonable to suggest that the patient should be given cytotoxic chemotherapy over the period of the operation in an attempt to mitigate the effect of liberated cancer cells: there is ample experimental evidence to show the value of anti-cancer agents on free cancer cells in wounds and in the peritoneal cavity , McKibbin, Gazet, Hoppe & Schwab 1963 , McKibbin & Gazet 1964 . Certainly it is the practice in many centres to give such cover in conditions such as carcinoma of the lung and breast, during surgery (Cole et al. 1961) . We feel that we have shown a reasonable criterion for its use in hypemephroma.
It has therefore been our practice to give 500 mg cyclophosphamide intravenously with the premedication, 500 mg intravenously during operation, followed by the systemic administration of this dose post-operatively for at least two days. We claim no originality for this suggestion but believe we have rationalized its use. We feel that an attempt to cut down the viability of the cells liberated into the circulation by this tumour at operation may well play a significant part in improving prognosis.
The following papers were also read: The following demonstration was given: Three Interesting Vesical Calculi Dr G A K Missen The three calculi shown were as follows: (a) One of the cystine calculi from which the amino acid was first isolated by Wollaston (Wollaston 1 810, Griffiths et al. 1964 ). (b) The calculus whose removal gave rise to the case of Bransby Cooper v. Wakley (Brook 1945) . (c) A calculus containing methylene blue (Missen 1960) .
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